{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T06:43:38Z","timestamp":1795157018316,"version":"4.10.3"},"reference-count":44,"publisher":"Bioscientifica","issue":"3","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":2175,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human immunodeficiency virus (HIV) is a pandemic affecting more than 35 million people worldwide. The aim of this review is to describe the association between HIV and total hip arthroplasty (THA) and assess patient risk factors to optimize functional outcomes and decrease rates of revision. Since the advent of highly active antiretroviral treatment (HAART), HIV-infected patients are living longer, which allows them to develop degenerative joint conditions. HIV and HAART act independently to increase the demand for THA. HIV-positive patients are also more predisposed to developing avascular necrosis (AVN) of the hip and femoral neck fractures due to decreased bone mineral density (BMD). Prior to the widespread implementation of access to HAART in homogenous cohorts of HIV-infected patients undergoing THA, reports indicated increased rates of complications. However, current literature describes equivocal functional outcomes and survival rates after THA in HIV-positive patients controlled on HAART when compared to HIV-negative controls. HIV-infected patients eligible for THA should be assessed for medical co-morbidities and serum markers of disease control should be optimized. Periprosthetic joint infection (PJI) is a leading cause of revision THA, and HIV is a modifiable risk factor. Importantly, the significance is negated once patients are placed on HAART and achieve viral suppression. THA should not be withheld in HIV-infected patients injudiciously. However, HIV is a burgeoning epidemic and all patients should be identified and started on HAART to avoid preventable peri-operative complications.<\/jats:p>\n                  <jats:p>Cite this article: EFORT Open Rev 2020;5:164-171. DOI: 10.1302\/2058-5241.5.190030<\/jats:p>","DOI":"10.1302\/2058-5241.5.190030","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T05:11:11Z","timestamp":1583125871000},"page":"164-171","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-16","source":"Crossref","is-referenced-by-count":18,"title":["Human immunodeficiency virus in total hip arthroplasty"],"prefix":"10.1530","volume":"5","author":[{"given":"Jurek Rafal Tomasz","family":"Pietrzak","sequence":"first","affiliation":[{"name":"1Arthroplasty Unit, Charlotte Maxeke Johannesburg Academic Hospital (CMJAH), Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9172-911X","authenticated-orcid":false,"given":"Zia","family":"Maharaj","sequence":"additional","affiliation":[{"name":"1Arthroplasty Unit, Charlotte Maxeke Johannesburg Academic Hospital (CMJAH), Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipalo","family":"Mokete","sequence":"additional","affiliation":[{"name":"1Arthroplasty Unit, Charlotte Maxeke Johannesburg Academic Hospital (CMJAH), Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkhodiseni","family":"Sikhauli","sequence":"additional","affiliation":[{"name":"1Arthroplasty Unit, Charlotte Maxeke Johannesburg Academic Hospital (CMJAH), Johannesburg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"2026070711291994300_bibr1-2058-5241.5.190030","unstructured":"UNAIDS factsheet, July2018. https:\/\/www.aidsinfo.unaids.org (date last accessed 10 April 2019)."},{"key":"2026070711291994300_bibr2-2058-5241.5.190030","unstructured":"Pharris\n              A\n            \n            \n              Stengaard\n              A\n            \n            \n              Amato-Gauci\n              AJ\n            \n            \n              Catchpole\n              M\n            \n            \n              Croxford\n              S\n            \n            \n              Dara\n              M\n            \n            et al.\n          ; . European Center for Disease Prevention and Control (ECDC) HIV\/AIDS surveillance in Europe 2018\u20132017 data. World Health Organization, 2018. https:\/\/ecdc.europa.eu\/en\/publications-data\/hivaids-surveillance-europe-2018-2017-data (date last accessed 10 April 2019)."},{"key":"2026070711291994300_bibr3-2058-5241.5.190030","unstructured":"Public Health England. HIV in the UK, 2016 report. https:\/\/www.gov.uk\/government\/publications\/hiv-in-the-united-kingdom (date last accessed 10 April 2019)."},{"key":"2026070711291994300_bibr4-2058-5241.5.190030","unstructured":"NJR Editorial Board. National Joint Registry 15th Annual Report 2018. Published 25September2018. https:\/\/www.hqip.org.uk\/resource\/national-joint-registry-15th-annual-report-2018\/ (date last accessed 10 April 2019)."},{"key":"2026070711291994300_bibr5-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","author":"Kurtz","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"2026070711291994300_bibr6-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1007\/s11999-017-5244-6","article-title":"Which clinical and patient factors influence the national economic burden of hospital readmissions after total joint arthroplasty?","volume":"475","author":"Kurtz","year":"2017","journal-title":"Clin Orthop Relat Res"},{"issue":"7S","key":"2026070711291994300_bibr7-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1016\/j.arth.2018.12.024","article-title":"Mortality during total hip periprosthetic joint infection","volume":"34","author":"Natshara","year":"2019","journal-title":"J Arthroplasty"},{"key":"2026070711291994300_bibr8-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.idc.2018.06.005","article-title":"Prosthetic joint infection update","volume":"32","author":"Beam","year":"2018","journal-title":"Infect Dis Clin North Am"},{"key":"2026070711291994300_bibr9-2058-5241.5.190030","first-page":"233","article-title":"Patient-related medical risk factors for periprosthetic joint infection of the hip and knee","volume":"3","author":"Eka","year":"2015","journal-title":"Ann Transl Med"},{"key":"2026070711291994300_bibr10-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1016\/j.arth.2018.02.066","article-title":"Choices, compromises, and controversies in total knee and total hip arthroplasty modifiable risk factors: what you need to know","volume":"33","author":"Edwards","year":"2018","journal-title":"J Arthroplasty"},{"key":"2026070711291994300_bibr11-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.arth.2018.09.050","article-title":"General assembly, prevention, host related general: proceedings of International Consensus on Orthopedic Infections","volume":"34","author":"Zainul-Abidin","year":"2019","journal-title":"J Arthroplasty"},{"key":"2026070711291994300_bibr12-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijantimicag.2014.02.011","article-title":"Protease inhibitors and avascular necrosis: a systematic review and meta-analysis","volume":"44","author":"Permpalung","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"2026070711291994300_bibr13-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00296-011-2114-5","article-title":"Avascular necrosis in HIV","volume":"33","author":"Mehta","year":"2013","journal-title":"Rheumatol Int"},{"key":"2026070711291994300_bibr14-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11914-012-0125-0","article-title":"HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options","volume":"10","author":"Rothman","year":"2012","journal-title":"Curr Osteoporos Rep"},{"key":"2026070711291994300_bibr15-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/511683","article-title":"The incidence and natural history of osteonecrosis in HIV-infected adults","volume":"44","author":"Morse","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2026070711291994300_bibr16-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.2106\/JBJS.RVW.17.00029","article-title":"Human immunodeficiency virus infection and hip and knee arthroplasty","volume":"5","author":"Dimitriou","year":"2017","journal-title":"JBJS Rev"},{"key":"2026070711291994300_bibr17-2058-5241.5.190030","unstructured":"Libman\n              H\n            \n            \n              Bartlett\n              JG\n            \n            \n              Bloom\n              A\n            \n          . Surgical issues in HIV infection. UpToDate Literature review current through: Oct2018. https:\/\/www.uptodate.com\/contents\/surgical-issues-in-hiv-infection\/ (date last accessed 7 November 2018)"},{"key":"2026070711291994300_bibr18-2058-5241.5.190030","unstructured":"Fletcher\n              CV\n            \n            \n              Bartlett\n              JG\n            \n            \n              Sax\n              PE\n            \n            \n              Mitty\n              J\n            \n          . Overview of antiretroviral agents used to treat HIV. UpToDate Literature review current through: Oct2018. https:\/\/www.uptodate.com\/contents\/overview-of-antiretroviral-agents-used-to-treat-hiv\/ (date last accessed 7 November 2018)"},{"key":"2026070711291994300_bibr19-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4102\/sajhivmed.v18i1.776","article-title":"Adult antiretroviral therapy guidelines 2017","volume":"18","author":"Meintjes","year":"2017","journal-title":"South Afr J HIV Med"},{"key":"2026070711291994300_bibr20-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9745\/GHSP-D-14-00243","article-title":"ARVs: the next generation. Going boldly together to new frontiers of HIV treatment","volume":"3","author":"Barnhart","year":"2015","journal-title":"Glob Health Sci Pract"},{"key":"2026070711291994300_bibr21-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2106\/JBJS.RVW.15.00117","article-title":"Total joint arthroplasty in patients with human immunodeficiency virus","volume":"4","author":"Shah","year":"2016","journal-title":"JBJS Rev"},{"key":"2026070711291994300_bibr22-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archsurg.141.12.1238","article-title":"Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy","volume":"141","author":"Horberg","year":"2006","journal-title":"Arch Surg"},{"key":"2026070711291994300_bibr23-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/jamasurg.2014.2257","article-title":"Thirty-day postoperative mortality among individuals with HIV infection receiving antiretroviral therapy and procedure-matched, uninfected comparators","volume":"150","author":"King","year":"2015","journal-title":"JAMA Surg"},{"key":"2026070711291994300_bibr24-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/M14-0954","article-title":"Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys","volume":"162","author":"Mdodo","year":"2015","journal-title":"Ann Intern Med"},{"key":"2026070711291994300_bibr25-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0883-5403(05)80065-8","article-title":"Postoperative infection following orthopaedic surgery in human immunodeficiency virus-infected hemophiliacs with CD4 counts &lt; or = 200\/mm3","volume":"10","author":"Ragni","year":"1995","journal-title":"J Arthroplasty"},{"key":"2026070711291994300_bibr26-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1054\/arth.2001.21454","article-title":"Infection after total joint arthroplasty in patients with human immunodeficiency virus or intravenous drug use","volume":"16","author":"Lehman","year":"2001","journal-title":"J Arthroplasty"},{"key":"2026070711291994300_bibr27-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.arth.2016.02.058","article-title":"Human immunodeficiency virus and total joint arthroplasty: the risk for infection is reduced","volume":"31","author":"Enayatollahi","year":"2016","journal-title":"J Arthroplasty"},{"key":"2026070711291994300_bibr28-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1054\/arth.2003.50094","article-title":"Total joint arthroplasty in human immunodeficiency virus-positive patients: an alarming rate of early failure","volume":"18","author":"Parvizi","year":"2003","journal-title":"J Arthroplasty"},{"key":"2026070711291994300_bibr29-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1302\/0301-620X.96B4.33213","article-title":"Total hip replacement in HIV-positive patients","volume":"96-B","author":"Graham","year":"2014","journal-title":"Bone Joint J"},{"key":"2026070711291994300_bibr30-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11999-014-3855-8","article-title":"Does HIV infection increase the risk of perioperative complications after THA? A nationwide database study","volume":"473","author":"Naziri","year":"2015","journal-title":"Clin Orthop Relat Res"},{"key":"2026070711291994300_bibr31-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.arth.2013.01.012","article-title":"Revision surgery after total joint arthroplasty: a complication-based analysis using worldwide arthroplasty registers","volume":"28","author":"Sadoghi","year":"2013","journal-title":"J Arthroplasty"},{"key":"2026070711291994300_bibr32-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2106\/JBJS.L.01583","article-title":"Outcomes of cementless primary THA for osteonecrosis in HIV-infected patients","volume":"95","author":"Issa","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"2026070711291994300_bibr33-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.arth.2018.11.001","article-title":"Total hip arthroplasty in human immunodeficiency virus-positive patients: a concise follow-up at 10 to 14 years","volume":"34","author":"Novikov","year":"2019","journal-title":"J Arthroplasty"},{"key":"2026070711291994300_bibr34-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2106\/JBJS.L.00269","article-title":"Comorbidities and perioperative complications in HIV-positive patients undergoing primary total hip and knee arthroplasty","volume":"95","author":"Lin","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"2026070711291994300_bibr35-2058-5241.5.190030","unstructured":"Center for Disease Prevention and Control (CDC). HIV surveillance report: diagnoses of HIV infection in the United States and dependent areas, 2017; vol. 29. https:\/\/www.cdc.gov\/hiv\/pdf\/library\/reports\/surveillance\/cdc-hiv-surveillance-report-2017-vol-29.pdf (date last accessed 10 April 2019)."},{"key":"2026070711291994300_bibr36-2058-5241.5.190030","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. Second ed. World Health Organization, 2016. https:\/\/www.who.int\/hiv\/pub\/guidelines\/ARV2018update\/en\/ (date last accessed 7 November 2018)."},{"key":"2026070711291994300_bibr37-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2018.8431","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the international antiviral society-USA panel","volume":"320","author":"Saag","year":"2018","journal-title":"JAMA"},{"key":"2026070711291994300_bibr38-2058-5241.5.190030","unstructured":"Waters\n              L\n            \n            \n              Ahmed\n              N\n            \n            \n              Angus\n              B\n            \n            \n              Boffito\n              M\n            \n            \n              Bower\n              M\n            \n            \n              Churchill\n              D\n            \n            et al.\n          \n          British HIV Association (BHIVA) guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015 (2016 interim update). https:\/\/www.bhiva.org\/file\/RVYKzFwyxpgiI\/treatment-guidelines-2016-interim-update.pdf (accessed 20 May 2019)."},{"key":"2026070711291994300_bibr39-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1302\/0301-620X.91B3.21706","article-title":"Joint replacement in Malawi: establishment of a national joint registry","volume":"91","author":"Lubega","year":"2009","journal-title":"J Bone Joint Surg Br"},{"key":"2026070711291994300_bibr40-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1468-1293.2012.01017.x","article-title":"Total hip arthroplasty in HIV-infected patients: a retrospective, controlled study","volume":"13","author":"Tornero","year":"2012","journal-title":"HIV Med"},{"key":"2026070711291994300_bibr41-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.arth.2012.12.021","article-title":"Infection rate following total joint arthroplasty in the HIV population","volume":"28","author":"Capogna","year":"2013","journal-title":"J Arthroplasty"},{"key":"2026070711291994300_bibr42-2058-5241.5.190030","first-page":"102","article-title":"Outcomes of total joint arthroplasty in HIV patients","volume":"34","author":"Falakassa","year":"2014","journal-title":"Iowa Orthop J"},{"key":"2026070711291994300_bibr43-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.arth.2013.04.023","article-title":"Outcomes of total hip arthroplasty in human immunodeficiency virus-positive patients","volume":"29","author":"Snir","year":"2014","journal-title":"J Arthroplasty"},{"key":"2026070711291994300_bibr44-2058-5241.5.190030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.arth.2013.06.015","article-title":"Mid-term outcomes in HIV-positive patients after primary total hip or knee arthroplasty","volume":"29","author":"Lin","year":"2014","journal-title":"J Arthroplasty"}],"container-title":["EFORT Open Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/pdf\/10.1302\/2058-5241.5.190030","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/online.boneandjoint.org.uk\/doi\/full-xml\/10.1302\/2058-5241.5.190030","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/eor\/article-pdf\/5\/3\/164\/17318\/2058-5241.5.190030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eor\/article-pdf\/5\/3\/164\/17318\/2058-5241.5.190030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:12:46Z","timestamp":1783440766000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/eor\/article\/5\/3\/164\/2247\/Human-immunodeficiency-virus-in-total-hip"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,2]]},"published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1302\/2058-5241.5.190030","relation":{},"ISSN":["2058-5241"],"issn-type":[{"value":"2058-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}